PAL members AFSCME District Council 37 Health and Security Plan and New England Carpenters Benefits Fund filed a class action lawsuit against First Databank Inc. and McKesson Corporation (NYSE: MCK) in 2005, alleging that the two companies conspired to a

Dan Greenberg, author of Science for Sale: The Perils, Delusions and Rewards of Campus Capitalism and blogger at the Chronicle of Higher Education posted a list of information he thinks “should be posted in a public database and maybe even on the front pa

The state of Alaska is suing Eli Lilly (NYSE:LLY) for failing to disclose health risks (like diabetes and weight gain) allegedly associated with Lilly's hugely profitable "atypical antipsychotic" drug Zyprexa. Last week, attorneys for the state rested t

Last week, we pointed to a story about a settlement Fidelity Investments made with the SEC after word emerged about some pretty opulent VIP handouts from brokers to some Fidelity traders whose business they were courting, including Superbowl tickets, booz

The title of this post is one of the many questions that came to mind when I read yesterday's New York Times story, Cutting Dosage of Costly Drug Spurs a Debate. The article describes the cost of Cerezyme, a drug made by Genzyme (GENZ). As the Times rep

PostScript goes to the Hill this week, where the Senate Aging Committee held a hearing on academic detailing, the practice of providing doctors with unbiased, evidence-based drug information to counteract pharmaceutical sales pitches.  The hearing was hel

In case you thought Canadians were less conflicted: A University of Toronto publication reports that Dr. Claire Bombardier has just been named to a new rheumatology research chair in the Faculty of Medicine. Who is Bombardier? She was the lead author of V

CNNMoney.com reported yesterday this little nugget: "Prescription drug sales rate hits 47 year low" Which suggests that drug sales were lower in 2007 than in the past 47 years, right? Wrong. Drug sales did NOT decrease in 2007. In fact, far from it. A

Gift ban part of Sen. Murray's health care bill On Wednesday, the Massachusetts Joint Health Care Financing committee will hear Senate President Therese Murray’s health care cost and quality. The Prescription Project, a member of the Massachusetts Prescri